Suppr超能文献

不同产地五味子(Turcz.)Baill.木脂素含量-评价中药主要成分含量的新模型。

Lignan contents of Schisandra chinensis (Turcz.) Baill. from different origins-A new model for evaluating the content of prominent components of Chinese herbs.

机构信息

College of Life Sciences, Northwest A&F University, Yangling 712100, China.

College of Life Sciences, Northwest A&F University, Yangling 712100, China.

出版信息

Phytomedicine. 2024 Jun;128:155361. doi: 10.1016/j.phymed.2024.155361. Epub 2024 Jan 15.

Abstract

BACKGROUND

As a traditional Chinese herbal medicine, Schisandra chinensis exhibits various effects such as liver protection, blood sugar regulation, blood lipid regulation, immune function regulation, antidepressant activity, etc. However, because of its intricate composition, diverse origins, and medicinal effects depending on complex compound groups, there are differences in the lignan composition of S. chinensis from different origins. Therefore, it is currently difficult to evaluate the quality of medicinal materials from plants of different origins using a single qualitative quality control index.

PURPOSE

This paper aims to investigate the potential relationship between the lignan components of S. chinensis from different origins and to establish stable assessment indices for determining the lignan content of S. chinensis from multiple perspectives.

METHODS

In this study, we collected S. chinensis samples of seven major origins in China, and randomly sampled 6-9 batches of each origin for a total of 60 batches. The lignan content was determined by HPLC, and its distribution law of the ratio of each lignan component of S. chinensis to Schisandrol A content was analyzed. Combining network pharmacology and differential analysis between samples, the stable and effective substances used as quality markers were determined.

RESULTS

There were some correlations among the lignan contents of S. chinensis, some correlations between schisandrin A and other lignans of S. chinensis could be determined. The ratio of each component to the indicator component schisandrol A was evenly distributed and reflected the lignan content of S. chinensis to some extent. Four substances (schisandrol A, schisandrol B, schisantherin A, and schisandrin C) were determined by network pharmacology combined with the analysis results of HCA, PCA and PLS-DA to further optimize the model. They displayed a strong connection with the core target, a large contribution rate to the principal components, and a stable content in each batch of samples, suggesting that these components may be the main active substances of S. chinensis lignans. Therefore, they could be used as main indicators evaluating the advantages and disadvantages of S. chinensis by examining the consistency of component proportions.

CONCLUSION

This method can intuitively evaluate the content of main lignans in S. chinensis. This quality assessment model is an exploration of the multi-component comprehensive evaluation system of S. chinensis, providing a new concept for the quality evaluation system of Chinese herbal medicines.

摘要

背景

五味子作为一种传统的中草药,具有护肝、调节血糖、调节血脂、调节免疫功能、抗抑郁等多种功效。然而,由于其成分复杂、来源多样,且药效依赖于复杂的化合物群,不同产地的五味子中木脂素成分存在差异。因此,目前难以用单一的定性质量控制指标来评价不同产地的药材质量。

目的

本研究旨在探讨不同产地五味子木脂素成分之间的潜在关系,并建立从多个角度确定五味子木脂素含量的稳定评价指标。

方法

本研究收集了中国七大主产地的五味子样品,每个产地随机抽取 6-9 批,共 60 批。采用高效液相色谱法测定木脂素含量,分析五味子各木脂素成分与五味子醇甲含量的比值分布规律。结合网络药理学和样品间差异分析,确定稳定有效的作为质量标志物的物质。

结果

五味子木脂素含量之间存在一定的相关性,某些情况下可以确定五味子醇甲与其他五味子木脂素之间的相关性。各成分与指标成分五味子醇甲的比值分布均匀,在一定程度上反映了五味子木脂素的含量。通过网络药理学结合 HCA、PCA 和 PLS-DA 的分析结果,确定了 4 种物质(五味子醇甲、五味子醇乙、五味子甲素和五味子丙素),进一步优化模型。这些物质与核心靶点连接紧密,对主成分的贡献率大,且在每批样品中的含量稳定,提示这些成分可能是五味子木脂素的主要活性物质。因此,通过检查成分比例的一致性,可以将这些成分作为评价五味子优劣的主要指标。

结论

该方法可以直观地评价五味子中主要木脂素的含量。该质量评价模型是对五味子多成分综合评价体系的探索,为中药质量评价体系提供了新的思路。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验